论文部分内容阅读
To compare the efficacy and safety of two doses of clotrimazole vaginal tablet 500mg with two doses of oral fluconazole 150mg in treating severe vulvovaginal candidiasis (SVVC),240 consecutive patients with SVVC were studied at the Department of Obstetrics and Gynaecology of Peking University Shenzhen Hospital between June 2014,and September 2015.Patients were randomly assigned in a 1∶1 ratio to receive treatment with either two doses of clotrimazole vaginal tablet or two doses of oral fluconazole.The clinical cure rates in the clotrimazole group and the fluconazole group at days 7-14 follow-up were 88.7% (102/115) and 89.1% (98/110),respectively;the clinical cure rates at days 30-35 in the two groups were 71.9% (82/114) and 78.0% (85/109),respectively.The mycological cure rates at days 7-14 follow-up in the two groups were 78.3% (90/115) and 73.6% (81/110),respectively.The mycological cure rates of the patients at days 30-35 in the two groups were 54.4% (62/114) and 56.0% (61/109),respectively (p>0.05).The adverse events of clotrimazole were mainly local.This study demonstrated that two doses of clotrimazole vaginal tablet 500mg were as effective as two doses of oral fluconazole 150mg in the treatment of patients with SVVC and could be an appropriate treatment for this disorder.